𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma

✍ Scribed by Sommerer, Florian; Vieth, Michael; Markwarth, Annett; Röhrich, Knut; Vomschloß, Susanne; May, Andrea; Ell, Christian; Stolte, Manfred; Hengge, Ulrich R; Wittekind, Christian

Book ID
110068270
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
220 KB
Volume
23
Category
Article
ISSN
0950-9232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequency of KRAS, BRAF, and NRAS mutati
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer
✍ Cecily P. Vaughn; Scott D. ZoBell; Larissa V. Furtado; Christine L. Baker; Wade 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract Mutational analysis of __KRAS__ codons 12 and 13 is standard for patients with metastatic colorectal cancer since mutations in these codons predict lack of response to anti‐EGFR therapies. However, even among patients whose tumors are wildtype for __KRAS__ codons 12 and 13, only a subse

Prognostic value of loss of heterozygosi
Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma
✍ Laura De Gregorio; Giacomo Manenti; Matteo Incarbone; Silvana Pilotti; Ugo Pasto 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 89 KB

The prognostic values of loss of heterozygosity (LOH) at loci frequently involved in non-small cell lung cancer and of KRAS2 gene mutations were studied in lung adenocarcinoma patients. LOHs were relatively common, ranging from 24% at chromosome 10p to 55% at chromosome 17p13. KRAS2 mutations at cod

Mutations of BRAF and KRAS in gastric ca
Mutations of BRAF and KRAS in gastric cancer and their association with microsatellite instability
✍ Wei Zhao; Tsun Leung Chan; Kent-Man Chu; Annie S. Chan; Michael R. Stratton; Siu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 53 KB 👁 1 views

## Dear Sir, The RAS proteins participate in the RAS-RAF-MEK-ERK-MAPKinase pathway, which mediates cellular responses to growth signals. 1 There are 3 RAF genes, each encoding cytoplasmic serine/threonine kinases that are regulated by binding to RAS. 1,2 We have recently reported that BRAF is soma

TRAIL receptor upregulation and the impl
TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors
✍ Eftychia Oikonomou; Vivian Kosmidou; Anastasia Katseli; Konstantinos Kothonidis; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 273 KB 👁 2 views

## Abstract TRAIL raises hopes as a promising anti‐tumor agent due to its selectivity toward cancer cells. Higher expression of its pro‐death receptors TRAIL‐R1 (DR4) and TRAIL‐R2 (DR5) attenuates higher sensitivity to TRAIL‐induced apoptosis, and represents a marker for better cancer prognosis and